Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline
Open accessAbstract
Introduction This guideline establishes clinical practice recommendations for positive airway pressure (PAP) treatment of obstructive sleep apnea (OSA) in adults and is intended for use in conjunction with other American Academy of Sleep Medicine (AASM) guidelines in the evaluation and treatment of sleep-disordered breathing in adults.Methods The AASM commissioned a task force of experts in sleep medicine. A systematic review was conducted to identify studies, and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) process was used to assess the evidence. The task force developed recommendations and assigned strengths based on the quality of evidence, the balance of clinically significant benefits and harms, patient values and preferences, and resource use. In addition, the task force adopted recommendations from prior guidelines as "good practice statements" that establish the basis for appropriate and effective treatment of OSA. The AASM Board of Directors approved the final recommendations.Good practice statements The following good practice statements are based on expert consensus, and their implementation is necessary for appropriate and effective management of patients with OSA treated with positive airway pressure: (1) Treatment of OSA with PAP therapy should be based on a diagnosis of OSA established using objective sleep apnea testing. (2) Adequate follow-up, including troubleshooting and monitoring of objective efficacy and usage data to ensure adequate treatment and adherence, should occur following PAP therapy initiation and during treatment of OSA.Recommendations The following recommendations are intended as a guide for clinicians using PAP to treat OSA in adults. A STRONG (ie, "We recommend…") recommendation is one that clinicians should follow under most circumstances. A CONDITIONAL recommendation (ie, "We suggest…") reflects a lower degree of certainty regarding the outcome and appropriateness of the patient-care strategy for all patients. The ultimate judgment regarding any specific care must be made by the treating clinician and the patient, taking into consideration the individual circumstances of the patient, available treatment options, and resources. (1) We recommend that clinicians use PAP, compared to no therapy, to treat OSA in adults with excessive sleepiness. (STRONG) (2) We suggest that clinicians use PAP, compared to no therapy, to treat OSA in adults with impaired sleep-related quality of life. (CONDITIONAL) (3) We suggest that clinicians use PAP, compared to no therapy, to treat OSA in adults with comorbid hypertension. (CONDITIONAL) (4) We recommend that PAP therapy be initiated using either APAP at home or in-laboratory PAP titration in adults with OSA and no significant comorbidities. (STRONG) (5) We recommend that clinicians use either CPAP or APAP for ongoing treatment of OSA in adults. (STRONG) (6) We suggest that clinicians use CPAP or APAP over BPAP in the routine treatment of OSA in adults. (CONDITIONAL) (7) We recommend that educational interventions be given with initiation of PAP therapy in adults with OSA. (STRONG) (8) We suggest that behavioral and/or troubleshooting interventions be given during the initial period of PAP therapy in adults with OSA. (CONDITIONAL) (9) We suggest that clinicians use telemonitoring-guided interventions during the initial period of PAP therapy in adults with OSA. (CONDITIONAL).
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Data were insufficient to analyze differences in quality of life or interface-associated side effects.
“Data were insufficient to perform analyses examining differences in QOL or interface-associated side effects.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The Mask Selection section (page unavailable) reports analyses of both outcomes: studies found no clinically significant QOL difference between intranasal and nasal interfaces, and fewer side effects with nasal than with oronasal or oral interfaces. It therefore contradicts the claim that data were insufficient to analyze QOL or interface-associated side effects. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe effect of CPAP on blood pressure appears sustained over time with continued use, and some evidence suggests fixed CPAP devices may be better at decreasing blood pressure than auto-titrating devices, although better-tolerated APAP may be used for longer durations.
“The effect on BP appears to be sustained over time with continued use of CPAP and some evidence suggests that fixed CPAP devices may be better at decreasing BP than auto-titrating devices (APAP), although better tolerated APAP may be used for longer durations.39”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
Split into 2 atoms — 0 confirmed, 1 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredCurrent guidelines for the treatment of OSA typically take into account several factors including the AHI, presence or absence of symptoms, and associated comorbidities.
“Current guidelines for the treatment of OSA typically take into account several factors including the AHI, presence or absence of symptoms, and associated comorbidities.39”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The PAP Therapy recommendations (page unavailable in our copy) consider symptoms such as excessive sleepiness and impaired sleep-related quality of life; the hypertension recommendation considers a comorbidity. The guideline does not establish AHI-based treatment recommendations: its discussion of hypertension says the evidence did not permit recommendations specific to OSA severity. Thus the cited guideline supports some, but not all, of the factors listed. (LLM, conf=0.87)
Experimental — accuracy not yet measuredA systematic review by Patil et al. demonstrated that CPAP produces a clinically significant reduction in obstructive sleep apnea severity, evidenced by complete or near resolution of the apnea-hypopnea index.
“An SR by Patil et al.39 demonstrated a clinically significant reduction in disease severity as evidenced by complete resolution or near resolution of the AHI”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The Methods section (page unavailable) says this guideline draws on a systematic review of PAP treatment, and Recommendation 5 supports CPAP for ongoing treatment of adult OSA. But the cited paper is a clinical practice guideline that identifies the systematic review as a separate companion paper; our copy does not report complete or near-complete resolution of AHI with CPAP. Searches for AHI and residual OSA did not establish that specific outcome. (LLM, conf=0.78)
Experimental — accuracy not yet measuredThe same systematic review found that CPAP improves subjective sleepiness, with an ESS reduction of 2.4 points based on meta-analysis of 38 randomized controlled trials, and improves ability to maintain wakefulness on the Maintenance of Wakefulness Test.
“improvement in subjective sleepiness (reduction in ESS score of 2.4 points based on metanalysis of 38 RCTs, and ability to maintain wakefulness based on the Maintenance of Wakefulness Test [MWT])”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Bilevel PAP confers no significant advantage over CPAP or APAP in improved adherence, except as a potential therapy option for patients nonadherent to CPAP.
“BPAP also confers no significant advantage over CPAP or APAP in improved adherence, except as a potential therapy option for patients nonadherent to CPAP.39”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
Recommendation 6 (page unavailable) reports no clinically significant adherence difference between BPAP and CPAP; it treats APAP as equivalent to CPAP for this recommendation, though it found no direct BPAP–APAP comparison. It offers a BPAP trial for patients unable to tolerate CPAP or APAP because of high pressure requirements despite modified pressure profiles, including after demonstrated non-acceptance. That is narrower than recommending BPAP for patients nonadherent to CPAP generally. (LLM, conf=0.87)
Experimental — accuracy not yet measuredTwo systematic reviews found that APAP and CPAP both produce clinically significant reductions in apnea-hypopnea index, sleepiness measured by ESS, and quality of life, with no significant difference between the two modalities.
“Two SRs39,1035 evaluated the differences between APAP and CPAP devices. Both modalities resulted in a clinically significant reduction of the AHI, sleepiness as measured by the ESS, and QOL. There was no significant difference between the two treatment modalities.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
Recommendation 5 (page unavailable) reports meta-analyses of 26 trials finding no clinically significant differences between APAP and CPAP in sleepiness or quality of life. It does not establish the claimed clinically significant reductions in AHI, ESS-measured sleepiness, and quality of life for both modalities; its comparison addresses differences between treatments, not those specific improvements. (LLM, conf=0.87)
Experimental — accuracy not yet measuredOronasal mask use produces higher residual AHI than nasal interfaces, but the difference is not clinically significant.
“Residual AHI was higher using oronasal masks compared to nasal interfaces, though the difference was not clinically significant.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The Mask Selection section (page unavailable) says the guideline reviewed studies of PAP interfaces and AHI, and compares nasal with oronasal interfaces on adherence and side effects. It does not report that residual AHI was higher with oronasal masks or that an AHI difference was clinically insignificant; its clinical-significance finding concerns adherence. (LLM, conf=0.78)
Experimental — accuracy not yet measuredThe systematic review by Patil et al. did not demonstrate any difference in PAP adherence between APAP and CPAP as measured by hours used, nights used, or nights used with greater than 4 hours of usage per night.
“The SR by Patil et al.39 did not demonstrate any difference in PAP adherence as measured by hours used, nights used, or nights used with greater than 4 h of usage per night.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
Recommendation 5 (page unavailable) reports that meta-analyses found no clinically significant difference in treatment adherence between APAP and CPAP. The guideline does not give results for the three specified measures—hours used, nights used, or nights with more than four hours of use—and identifies itself as a guideline informed by a separately cited systematic review. (LLM, conf=0.87)
Experimental — accuracy not yet measuredPatil et al. found similar effects on obstructive sleep apnea severity, sleepiness, and adherence when PAP was initiated with home APAP without laboratory titration compared with in-laboratory CPAP titration.
“Patil et al.39 examined the comparison between in-lab titration of CPAP and home APAP (without lab titration) for initiation of PAP therapy. Analysis showed similar effects on OSA severity, sleepiness, and adherence with APAP initiated at home.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
In “Initiation of PAP Therapy” (page not provided), the guideline reports no clinically significant differences in sleepiness or adherence between home APAP initiation and in-laboratory PAP titration. It does not report a comparable finding for OSA severity in that comparison; the recommendation is also limited to adults without significant comorbidities. (LLM, conf=0.90)
Experimental — accuracy not yet measuredReview of studies showed no significant difference between bilevel PAP, CPAP, and APAP for improvement in obstructive sleep apnea severity, sleepiness, and quality of life.
“Review of studies showed no significant difference between BPAP, CPAP, and APAP for the improvement in OSA severity, sleepiness, and QOL.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
Recommendation 6 reports no clinically significant differences between BPAP and CPAP in residual OSA, self-reported sleepiness, or sleep-related quality of life. It explicitly says there was no direct evidence comparing BPAP with APAP; treating APAP as equivalent to CPAP was an inference for the recommendation, not a result shown by those studies. The claim also says “no significant difference” where the guideline specifies “no clinically significant differences.” (LLM, conf=0.88)
Experimental — accuracy not yet measuredA systematic review and meta-analysis of 10 RCTs found high-grade evidence that both at-home APAP and in-lab PAP titration are effective in reducing OSA severity, daytime sleepiness, and for PAP adherence and quality-of-life measures.
“An SR and MA of 10 RCTs comparing APAP at-home and in-lab PAP titration for initiation of PAP demonstrates high grade evidence that both approaches are effective in reducing OSA severity (AHI), daytime sleepiness, and for PAP adherence and QOL measures.39”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The Initiation of PAP Therapy section identifies 10 RCTs comparing home APAP initiation with laboratory titration and rates the evidence for its recommendation as high quality. It reports no clinically significant difference between approaches in adherence, sleepiness, or quality of life and recommends either approach for adults with OSA without significant comorbidities. It does not report that this 10-trial analysis found a reduction in OSA severity measured by AHI, so that attributed outcome is unsupported. (LLM, conf=0.88)
Experimental — accuracy not yet measuredThe systematic review by Patil et al. found moderate-quality evidence that PAP adherence increased by 0.6 hours per night with an educational intervention.
“Additionally, the SR by Patil et al. showed moderate quality evidence that PAP adherence increased by 0.6 h/night with an educational intervention and is the basis for the AASM guidelines that strongly recommends the use of education with PAP therapy.39”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The guideline’s educational and behavioral interventions discussion reports improved PAP adherence with educational interventions and rates the evidence as moderate; Recommendation 7 strongly recommends education before PAP initiation in adults with OSA. Our copy gives no 0.6-hour-per-night estimate, and its Methods section directs readers to a separate companion systematic review for detailed evidence. The numerical claim is therefore not supported by this cited guideline. (LLM, conf=0.87)
Experimental — accuracy not yet measuredThe same 2019 systematic review showed a significant reduction in incidence of side effects based on three RCTs, two of which were included in the 2018 review.
“However, it did show a significant reduction in incidence of side effects based on three RCTs, two of which were included in the 2018 review.39”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The Humidified PAP section reports a clinically significant reduction in several PAP-related side effects. It identifies nine RCTs evaluating humidification, however, and does not say the side-effect finding was based on three RCTs or that two appeared in a 2018 review. The Methods section also distinguishes this clinical practice guideline from its accompanying systematic review; no page numbers were available in our copy. (LLM, conf=0.83)
Experimental — accuracy not yet measuredThat SR's meta-analysis of seven RCTs showed a reduction in MWT or OSLER sleep latency of 0.5 min (95% CI 0.2-0.8) with PAP versus control.
“An MA of seven RCTs showed a reduction in MWT or Oxford Sleep Resistance Test (OSLER) sleep latency by 0.5 min in subjects treated with PAP (95% CI: 0.2, 0.8) compared to control subjects.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The PAP Therapy section (page unavailable) reports that meta-analyses of RCTs found improved sleepiness with PAP versus no treatment in adults with OSA. It does not report a seven-RCT analysis, MWT or OSLER sleep latency, or the claimed 0.5-minute estimate and confidence interval; it identifies 38 RCTs assessing sleepiness overall. (LLM, conf=0.86)
Experimental — accuracy not yet measuredAn earlier meta-analysis found conflicting conclusions on all-cause mortality: a meta-analysis of four RCTs showed CPAP did not reduce all-cause mortality with variable adherence, while a meta-analysis of nine non-RCTs showed a clinically significant reduction with risk ratio 0.4 (95% CI 0.24-0.69).
“The MA of four RCTs demonstrated that CPAP therapy did not reduce all-cause mortality; however, there was variability in CPAP adherence among the four trials. An MA of nine non-RCTs did demonstrate a clinically significant reduction in all-cause mortality with CPAP with a risk ratio of 0.4 (95% CI 0.24–0.69).”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredMultiple SRs have consistently shown CPAP is effective at reducing AHI.
“Multiple SRs have consistently demonstrated that CPAP is effective at reducing the AHI.39,1201,1202”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The Mask Selection section says studies evaluated whether PAP interfaces reduce AHI, and Recommendation 6 discusses meta-analyses comparing residual OSA with BPAP versus CPAP. Neither passage reports that CPAP reduced AHI or that multiple systematic reviews consistently demonstrated such a reduction. (LLM, conf=0.77)
Experimental — accuracy not yet measuredA recent SR of PAP versus control found a clinically significant decrease in ESS of 2.4 points (95% CI −2.8 to −1.9) in a meta-analysis of 38 RCTs.
“The MA of 38 RCTs demonstrated a clinically significant decrease in ESS score by 2.4 points in subjects using PAP compared with controls (95% CI: −2.8, −1.9).”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The PAP Therapy section (Recommendation 1; page unavailable in our copy) identifies 38 RCTs and says meta-analyses found a clinically significant improvement in sleepiness with PAP versus no treatment. It does not give an ESS decrease of 2.4 points or the stated 95% confidence interval, so those numerical details are not supported by this paper’s text. (LLM, conf=0.87)
Experimental — accuracy not yet measuredDespite the importance of long-term PAP therapy for chronic OSA, current emphasis is on the initial 3 months and limited data exist on long-term PAP after 3 months; long-term guidelines are based on expert opinion.
“Despite the importance of long-term PAP therapy for chronic OSA, the current emphasis is on the initial 3 months of PAP,39 and there are limited data on long-term PAP after 3 months; therefore, long-term guidelines are based on expert opinion.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The Good Practice Statements (page unavailable) describe OSA as chronic and call for close follow-up in the initial weeks to months, followed by periodic evaluation. They do not set a three-month cutoff or say that data after three months are limited. The Methods and Recommendation 5 (pages unavailable) describe evidence review and a strong recommendation for ongoing PAP treatment, rather than characterizing long-term guidance as based on expert opinion. (LLM, conf=0.86)
Experimental — accuracy not yet measuredSeveral SRs and meta-analyses have noted reductions in blood pressure with CPAP treatment of OSA, particularly moderate-to-severe OSA, but caution is warranted due to heterogeneity in pooled studies.
“Although several SRs and meta-analyses have noted reductions in BP with CPAP treatment of OSA, particularly moderate to severe OSA, caution is warranted because of heterogeneity in the pooled studies.39,654,1207–1211”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The guideline’s blood-pressure discussion (page unavailable) reports clinically significant reductions in its meta-analyses and says most included studies recruited patients with predominantly moderate-to-severe OSA. It cautions that blood pressure was not systematically reported by OSA severity, but attributes the moderate quality of evidence to imprecision, not heterogeneity in pooled studies. Thus, the stated reason for caution is not supported by this source. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe magnitude of 24-hour mean blood pressure reduction with CPAP for OSA is modest, about 2-4 mmHg, and may relate to OSA severity and nightly device usage hours.
“The magnitude of reduction of 24-h mean BP with CPAP treatment of OSA is modest, in the range of 2–4 mmHg, may be related to the severity of OSA1213 and to the number of hours of nightly usage of the device.39,1207–1209”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The guideline’s Recommendation 3 discussion (page unavailable) reports reductions in 24-hour systolic and diastolic blood pressure with PAP in adults with OSA and hypertension. It does not give a 2–4 mmHg reduction or link the reduction to nightly usage hours; it explicitly says the studies did not systematically report blood-pressure outcomes by OSA severity. (LLM, conf=0.88)
Experimental — accuracy not yet measuredThese meta-analyses showed a significant decrease in nighttime blood pressure and a long-term (12 weeks) reduction in mean and diastolic blood pressure with CPAP use of 4 or more hours per night.
“These meta-analyses have shown a significant decrease in nighttime BP as well as a long-term (12 weeks) reduction in mean and diastolic BP with CPAP device usage of 4 or more hours a night.39,1210,1211”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The guideline’s blood-pressure discussion (section labeled “AASM = American Academy of Sleep Medicine”; page unavailable) reports clinically meaningful reductions in nighttime blood pressure in meta-analyses of PAP therapy for adults with OSA and hypertension. It does not establish the claimed 12-week reduction in mean and diastolic blood pressure specifically with CPAP use of at least four hours per night. (LLM, conf=0.88)
Experimental — accuracy not yet measuredIndividuals with OSA who report daytime sleepiness appear to have greater decline in blood pressure compared with those who are not sleepy.
“Individuals with OSA who report daytime sleepiness appear to demonstrate greater decline in BP compared to those who are not sleepy.39,1211”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
In the PAP Therapy section (page unavailable), the guideline reports blood-pressure reductions with PAP in patients with OSA and hypertension. It says sleepy patients may be more accepting of PAP and may receive blood-pressure benefits, but it does not report a greater blood-pressure decline in sleepy than in non-sleepy patients. (LLM, conf=0.84)
Experimental — accuracy not yet measuredPAP therapy is considered first-line for the hypersomnic OSA patient.
“PAP therapy is considered first-line for the hypersomnic OSA patient [55].”
From Overview of sleep management during COVID-19. (2022) · cites this paper as [55]
The same systematic review found that CPAP improves sleep-related quality of life and blood pressure.
“sleep related QOL; and BP.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
A systematic review of PAP treatments for obstructive sleep apnea found no benefit for bilevel PAP over CPAP.
“An SR of PAP treatments for OSA found no benefit for BPAP over CPAP.39”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The systematic review by Patil et al. noted insufficient and inconclusive evidence to either recommend or withhold PAP to treat non-sleepy adults with obstructive sleep apnea to reduce cardiovascular events or mortality.
“there is “insufficient and inconclusive evidence to either recommend or withhold PAP to treat non-sleepy adults with OSA as a means to reduce CV events or mortality.””
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
Sleepiness does not differ significantly between oronasal and nasal masks, nor between nasal pillows and nasal masks.
“No significant differences in sleepiness were observed in comparisons of oronasal and nasal masks, nor in comparisons between nasal pillows and nasal masks.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
Adherence is significantly higher with nasal interfaces than with oronasal interfaces.
“however, adherence was significantly higher with nasal interfaces compared to oronasal interfaces.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
CPAP adherence is similar for nasal pillows and nasal interfaces.
“Adherence to CPAP was similar when intranasal (nasal pillows) and nasal interfaces were compared”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
A 2019 systematic review by Patil et al. of nine RCTs showed no clinically significant difference in adherence with or without humidification.
“Another SR by Patil et al. in 2019 reviewed nine RCTs, also showed no clinically significant difference in adherence with or without humidification.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
A meta-analysis of five randomized controlled trials measuring left ventricular ejection fraction by echocardiography or radionuclide ventriculography compared CPAP with control conditions in patients with heart failure with reduced ejection fraction; some studies showed modest improvements in absolute LVEF, but most reported changes were typically less than 5% and not considered clinically значим
“Patil et al. performed an MA of five RCTs measuring LVEF by echocardiography or radionuclide ventriculography to compare the efficacy of CPAP against control conditions in patients with hFrEF. While some studies showed modest improvements in the absolute value of LVEF associated with CPAP, most reported changes (typically less than 5%) that would not be considered clinically significant.39”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredThere is no evidence that treatment-emergent central sleep apnea poses harm to the patient.
“Nevertheless, there is no evidence that treatment-emergence central sleep apnea poses any harm to the patient.39”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The Initiation of PAP Therapy section says the trials underlying its recommendation excluded patients with central sleep apnea syndromes. A search for treatment-emergent central sleep apnea and patient harm found no passage in our copy assessing whether it causes harm. (LLM, conf=0.78)
Experimental — accuracy not yet measuredThat SR's meta-analysis of seven RCTs found no significant difference in mean sleep latency between PAP and control (mean difference 0.25 min, 95% CI −0.89 to 1.38).
“An MA of seven RCTs found no significant difference in mean sleep latency in subjects treated with PAP compared to controls (mean difference 0.25 min, 95% CI: −0.89, 1.38).”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
The PAP Therapy section reports improved sleepiness in a meta-analysis of 38 RCTs, but does not report a mean sleep-latency result. Searches for mean sleep latency, seven RCTs, and the stated mean difference and confidence interval found no passage addressing the specific claim in this guideline; its broader sleepiness finding does not settle it. (LLM, conf=0.75)
Experimental — accuracy not yet measuredA recent SR using two meta-analyses of 11 RCTs found one meta-analysis mean AHI decrease of 23 events/h with CPAP versus control and another meta-analysis mean decrease of 29 events/h pre- versus post-treatment; the mean difference was most pronounced when pre-treatment AHI was greater than 30 events/h.
“One MA demonstrated a mean decrease in AHI of 23 events/h with CPAP therapy compared to control interventions. The other MA showed a mean decrease in AHI of 29 events/h comparing subjects pre- and post-treatment. The mean difference in AHI was most pronounced in study groups where the mean pre-treatment AHI was greater than 30 events/h.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [39]
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Kapur, V. K., Auckley, D. H., Chowdhuri, S., Kuhlmann, D. C., Mehra, R., Ramar, K., & Harrod, C. G. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6506 · Cited by 3,253 · see citing works
Self-citationObjective Measurement of Patterns of Nasal CPAP Use by Patients with Obstructive Sleep Apnea
Kribbs, N. B., Pack, A. I., Kline, L. R., Smith, P. L., Schwartz, A. R., Schubert, N. M., Redline, S., Henry, J. N., Getsy, J. E., & Dinges, D. F. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.4.887 · Cited by 1,339 · see citing works
Kushida, C. A., Littner, M. R., Hirshkowitz, M., Morgenthaler, T. I., Alessi, C., Bailey, D. R., Boehlecke, B. A., Brown, T. M., Coleman, J., Friedman, L., et al. (2006) · SLEEP · doi:10.1093/sleep/29.3.375 · Cited by 774 · see citing works
Task Force Members, Kushida, C. A., Chediak, A., Berry, R. B., Brown, L. K., Gozal, D., Iber, C., Parthasarathy, S., Quan, S. F., & Rowley, J. A. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27133 · Cited by 749 · see citing works
Patil, S. P., Ayappa, I. A., Caples, S. M., Kimoff, R. J., Patel, S. R., & Harrod, C. G. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7638 · Cited by 721 · cited 1× · see citing works
“7 Taking these major factors into consideration, each recommendation statement was assigned a strength (STRONG or CONDITIONAL).”
Self-citationEvaluation of Positive Airway Pressure Treatment for Sleep Related Breathing Disorders in Adults
Gay, P., Weaver, T., Loube, D., & Iber, C. (2006) · Sleep · doi:10.1093/sleep/29.3.381 · Cited by 614 · see citing works
Night-To-Night Variability in CPAP Use Over the First Three Months of Treatment
Weaver, T. E., Kribbs, N. B., Pack, A. I., Kline, L. R., Chugh, D. K., Maislin, G., Smith, P. L., Schwartz, A. R., Schubert, N. M., Gillen, K. A., et al. (1997) · Sleep · doi:10.1093/sleep/20.4.278 · Cited by 530 · see citing works
Aurora, R. N., Chowdhuri, S., Ramar, K., Bista, S. R., Casey, K. R., Lamm, C. I., Kristo, D. A., Mallea, J. M., Rowley, J. A., Zak, R. S., et al. (2012) · Sleep · doi:10.5665/sleep.1580 · Cited by 369 · see citing works
Rosen, C. L., Auckley, D., Benca, R., Foldvary-Schaefer, N., Iber, C., Kapur, V., Rueschman, M., Zee, P., & Redline, S. (2012) · Sleep · doi:10.5665/sleep.1870 · Cited by 367 · see citing works
Morgenthaler, T. I., Aurora, R. N., Brown, T., Zak, R., Alessi, C., Boehlecke, B. A., Chesson, A. L., Friedman, L., Kapur, V. K., Maganti, R. K., et al. (2008) · SLEEP · doi:10.1093/sleep/31.1.141 · Cited by 333 · see citing works
Early CPAP Use Identifies Subsequent Adherence to CPAP Therapy
(2007) · Sleep · doi:10.1093/sleep/30.3.320 · Cited by 329 · see citing works
Berry, R. B., Chediak, A. D., Brown, L. K., Finder, J., Gozal, D., Iber, C., Kushida, C. A., Morgenthaler, T., Rowley, J. A., & Davidson-Ward, S. L. (2010) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27941 · Cited by 313 · see citing works
SANDERS, M. H., & Kern, N. B. (1990) · CHEST Journal · doi:10.1378/chest.98.2.317 · Cited by 290 · see citing works
Aurora, R. N., Bista, S. R., Casey, K. R., Chowdhuri, S., Kristo, D. A., Mallea, J. M., Ramar, K., Rowley, J. A., Zak, R. S., & Heald, J. L. (2016) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5812 · Cited by 112 · see citing works
McArdle, N., Singh, B., Murphy, M., Gain, K. R., Maguire, C., Mutch, S., & Hillman, D. R. (2010) · Thorax · doi:10.1136/thx.2009.116756 · Cited by 43 · see citing works
The Evolution of the AASM Clinical Practice Guidelines: Another Step Forward
Morgenthaler, T. I., Deriy, L., Heald, J. L., & Thomas, S. M. (2016) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5412 · Cited by 38 · see citing works
Friedman, L., Pancer, J. P., Boehlecke, B. A., Zak, R., Brown, T., Maganti, R. K., Aurora, R. N., Chesson, A. L., Swick, T. J., Owens, J. A., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/860c-ja22 · Cited by 21 · see citing works
Hui, D. S., Ng, S. S., & Tam, W. W. S. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201711-2185le · Cited by 9 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- [2]2. Kushida CA, Chediak A, Berry RB, et al. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med. 2008;4(2):157-171.
- [16]16. Aurora RN, Chowdhuri S, Ramar K, et al. The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep. 2012;35(1):17-40.
Cited by
Sorted by citations
Patil, S. P., Ayappa, I. A., Caples, S. M., Kimoff, R. J., Patel, S. R., & Harrod, C. G. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7638 · Cited by 721 · see citing works
Self-citationJones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., et al. (2025) · Hypertension · doi:10.1161/hyp.0000000000000249 · Cited by 386 · see citing works
International Consensus Statement on Obstructive Sleep Apnea
Chang, J. L., Goldberg, A. N., Alt, J. A., Mohammed, A., Ashbrook, L., Auckley, D., Ayappa, I., Bakhtiar, H., Barrera, J. E., Bartley, B. L., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23079 · Cited by 350 · see citing works
Self-citationJones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001356 · Cited by 295 · see citing works
Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., et al. (2025) · JACC · doi:10.1016/j.jacc.2025.05.007 · Cited by 280 · see citing works
Patel, S. R. (2019) · Annals of Internal Medicine · doi:10.7326/aitc201912030 · Cited by 269 · see citing works
Self-citationEvaluation and Management of Adults with Obstructive Sleep Apnea Syndrome
Lee, J. J., & Sundar, K. M. (2021) · Lung · doi:10.1007/s00408-021-00426-w · Cited by 251 · see citing works
Documento internacional de consenso sobre apnea obstructiva del sueño
Mediano, O., González Mangado, N., Montserrat, J. M., Alonso-Álvarez, M. L., Almendros, I., Alonso-Fernández, A., Barbé, F., Borsini, E., Caballero-Eraso, C., Cano-Pumarega, I., et al. (2022) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2021.03.017 · Cited by 250 · see citing works
Results of the ADHERE upper airway stimulation registry and predictors of therapy efficacy
Thaler, E., Schwab, R., Maurer, J., Soose, R., Larsen, C., Stevens, S., Stevens, D., Boon, M., Huntley, C., Doghramji, K., et al. (2020) · The Laryngoscope · doi:10.1002/lary.28286 · Cited by 182 · see citing works
Pengo, M. F., Soranna, D., Giontella, A., Perger, E., Mattaliano, P., Schwarz, E. I., Lombardi, C., Bilo, G., Zambon, A., Steier, J., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01945-2019 · Cited by 178 · see citing works
Sleep in chronic respiratory disease: COPD and hypoventilation disorders
McNicholas, W. T., Hansson, D., Schiza, S., & Grote, L. (2019) · European Respiratory Review · doi:10.1183/16000617.0064-2019 · Cited by 159 · see citing works
Sleep-related breathing disorders and pulmonary hypertension
Adir, Y., Humbert, M. J. C., & Chaouat, A. (2020) · European Respiratory Journal · doi:10.1183/13993003.02258-2020 · Cited by 146 · see citing works
Obesity and sleep disorders: A bidirectional relationship
Figorilli, M., Velluzzi, F., & Redolfi, S. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104014 · Cited by 125 · see citing works
Caples, S. M., Anderson, W. M., Calero, K., Howell, M. J., & Hashmi, S. D. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9240 · Cited by 119 · see citing works
Self-citationAskland, K. D., Wright, L., Wozniak, D. R., Emmanuel, T., Caston, J., & Smith, I. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007736.pub3 · Cited by 113 · see citing works
Kent, D. T., Stanley, J. J., Aurora, R. N., Levine, C. G., Gottlieb, D. J., Spann, M. D., Torre, C. A., Green, K., & Harrod, C. G. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9592 · Cited by 111 · see citing works
Self-citationKris‐Etherton, P. M., Petersen, K. H., Després, J., Anderson, C. A. M., DEEDWANIA, P. C., Furie, K. L., Lear, S. A., Lichtenstein, A. H., Lobelo, F., Morris, P. B., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001018 · Cited by 110 · see citing works
Obstructive Sleep Apnea and Cardiometabolic Disease: Obesity, Hypertension, and Diabetes
Tasali, E., Pamidi, S., Covassin, N., & Somers, V. K. (2025) · Circulation Research · doi:10.1161/circresaha.125.325676 · Cited by 100 · see citing works
Wimms, A. J., Kelly, J. L., Turnbull, C. D., McMillan, A., Craig, S. E., O'Reilly, J. F., Nickol, A. H., Hedley, E. L., Decker, M. D., Willes, L. A., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30402-3 · Cited by 95 · see citing works
REM sleep obstructive sleep apnoea
Bonsignore, M. R., Mazzuca, E., Baiamonte, P., Bouckaert, B., Verbeke, W., & Pevernagie, D. (2024) · European Respiratory Review · doi:10.1183/16000617.0166-2023 · Cited by 93 · see citing works
Treatment options in obstructive sleep apnea
Gambino, F., Zammuto, M. M., Virzì, A., Conti, G., & Bonsignore, M. R. (2022) · Internal and Emergency Medicine · doi:10.1007/s11739-022-02983-1 · Cited by 87 · see citing works
Meurling, J., Shea, D. O., & Garvey, J. (2019) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000627 · Cited by 86 · see citing works
Novel Aspects of CPAP Treatment and Interventions to Improve CPAP Adherence
Weaver, T. E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122220 · Cited by 86 · see citing works
Diet Composition and Objectively Assessed Sleep Quality: A Narrative Review
Wilson, K. K., St‐Onge, M., & Tasali, E. (2022) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.01.007 · Cited by 86 · see citing works
An Update on Obstructive Sleep Apnea Syndrome—A Literature Review
Platon, A. L., Stelea, C. G., Boișteanu, O., Pătrășcanu, E., Zetu, I. N., Rosu, S. N., Trifan, V., & Palade, D. O. (2023) · Medicina · doi:10.3390/medicina59081459 · Cited by 86 · see citing works
Determinants of Digital Payment Adoption Among Generation Z: An Empirical Study
Al-Qudah, A. A., Al‐Okaily, M., Shiyyab, F. S., Taha, A. A. D., Almajali, D., Masa’deh, R. M. T., & Warrad, L. H. (2024) · Journal of risk and financial management · doi:10.3390/jrfm17110521 · Cited by 85 · see citing works
Mészáros, M., & Bikov, A. (2022) · Biomedicines · doi:10.3390/biomedicines10112754 · Cited by 81 · see citing works
Bonsignore, M. R., Pépin, J., Cibella, F., Barbera, C. D. G., Marrone, O., Verbraecken, J. A., Saaresranta, T., Başoğlu, Ö. K., Trakada, G., Bouloukaki, I., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.690008 · Cited by 72 · see citing works
Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms
Yiangou, A., Mollan, S. P., & Sinclair, A. J. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00893-0 · Cited by 72 · see citing works
REM sleep behavior disorder: Mimics and variants
Antelmi, E., Lippolis, M., Biscarini, F., Tinazzi, M., & Plazzi, G. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101515 · Cited by 66 · see citing works
Alessi, C., Fung, C. H., Dzierzewski, J. M., Fiorentino, L., Stepnowsky, C. J., Tapia, J. C. R., Song, Y., Zeidler, M. R., Josephson, K. R., Mitchell, M. N., et al. (2020) · SLEEP · doi:10.1093/sleep/zsaa235 · Cited by 63 · see citing works
A Review of Current Tools Used for Evaluating the Severity of Obstructive Sleep Apnea
Cao, W., Luo, J., & Xiao, Y. (2020) · Nature and Science of Sleep · doi:10.2147/nss.s275252 · Cited by 60 · see citing works
Craig, S., Pépin, J., Randerath, W. J., Caussé, C., Verbraecken, J. A., Asin, J., Barbé, F., & Bonsignore, M. R. (2022) · European Respiratory Review · doi:10.1183/16000617.0230-2021 · Cited by 60 · see citing works
Comorbidities in COPD: Current and Future Treatment Challenges
Mariniello, D. F., D’Agnano, V., Cennamo, D., Conte, S., Quarcio, G., Notizia, L., Pagliaro, R., Schiattarella, A., Salvi, R., Bianco, A., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030743 · Cited by 60 · see citing works
Martínez-Cerón, E., Casitas, R., Galera, R., Sánchez-Sánchez, B., Zamarrón, E., García‐Sánchez, A., Oriol, A. J., Cubillos‐Zapata, C., & Rio, F. G. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.05.012 · Cited by 58 · see citing works
Impact of Sleep Disorder as a Risk Factor for Dementia in Men and Women
Jee, H. J., Shin, W., Jung, H. J., Kim, B., Lee, B. K., & Jung, Y.-S. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2019.192 · Cited by 57 · see citing works
Therapeutic Uses of Cannabis on Sleep Disorders and Related Conditions
Choi, S., Huang, B. C., & Gamaldo, C. E. (2019) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0000000000000617 · Cited by 56 · see citing works
Rosenberg, R. P., Schweitzer, P. K., Steier, J. S., & Pépin, J. (2021) · Postgraduate Medicine · doi:10.1080/00325481.2021.1948305 · Cited by 52 · see citing works
Overview of sleep management during COVID-19.
Becker, P. M. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2021.04.024 · Cited by 51 · see citing works
“PAP therapy is considered first-line for the hypersomnic OSA patient [55].”
BackgroundComorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. N., Викторович, А. М., Алексеева, Л. И., Almazova, I. I., Andreenko, Е. Y., Antipushina, D. N., Balanova, Y. А., et al. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-3996 · Cited by 49 · see citing works
Chen, C., Wang, J., Pang, L., Wang, Y., Ma, G., & Liao, W. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320901625 · Cited by 47 · see citing works
Kent, D. T., Stanley, J. J., Aurora, R. N., Levine, C. G., Gottlieb, D. J., Spann, M. D., Torre, C. A., Green, K., & Harrod, C. G. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9594 · Cited by 47 · see citing works
Self-citationMurphy, P. B., Patout, M., Arbane, G., Mandal, S., Kaltsakas, G., Polkey, M. I., Elliott, M., Muir, J., Douiri, A., Parkin, D. W., et al. (2022) · Thorax · doi:10.1136/thorax-2021-218497 · Cited by 46 · see citing works
Projecting the 30-year burden of obstructive sleep apnoea in the USA: a prospective modelling study
Boers, E., Barrett, M., Benjafield, A., Barnet, J. H., Ravelo, L. A., Kaye, L., Cistulli, P. A., Pépin, J., Armitstead, J. P., Sterling, K. L., et al. (2025) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(25)00243-7 · Cited by 46 · see citing works
Mandibular advancement device use in obstructive sleep apnea: ORCADES study 5-year follow-up data
Vecchierini, M., Attali, V., Collet, J.-M., d’Ortho, M., Goutorbe, F., Kerbrat, J.-B., Léger, D., Lavergne, F., Monaca, C. C., Monteyrol, P.-J., et al. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9308 · Cited by 46 · see citing works
Malhotra, A., Sterling, K. L., Cistulli, P. A., Pépin, J., Chen, J., Woodford, C., Alpert, N., More, S., Nuñez, C. M., & Benjafield, A. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202208-738oc · Cited by 43 · see citing works
Gunta, S. P., Jakulla, R. S., Ubaid, A., Mohamed, K., Bhat, A., López‐Candales, A., & Norgard, N. B. (2022) · Cardiovascular Therapeutics · doi:10.1155/2022/6006127 · Cited by 43 · see citing works
McCall, C. A., & Watson, N. F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020415 · Cited by 42 · see citing works
Defining obstructive sleep apnoea syndrome: a failure of semantic rules
Riha, R. L. (2021) · Breathe · doi:10.1183/20734735.0082-2021 · Cited by 41 · see citing works
The right interface for the right patient in noninvasive ventilation: a systematic review
Pierucci, P., Portacci, A., Carpagnano, G. E., Banfi, P., Crimi, C., Misseri, G., & Gregoretti, C. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2121706 · Cited by 40 · see citing works
Sleep Apnea, Sleepiness, and Driving Risk
Bonsignore, M. R., Marrone, O., & Fanfulla, F. (2019) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2019.08.001 · Cited by 40 · see citing works
Patil, S. P., Billings, M. E., Bourjeily, G. R., Collop, N. A., Gottlieb, D. J., Johnson, K. G., Kimoff, R. J., & Pack, A. I. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10832 · Cited by 39 · see citing works
Self-citationMultimorbidity in COPD, does sleep matter?
Vanfleteren, L. E. G. W., Beghé, B., Andersson, A., Hansson, D., Fabbri, L. M., & Grote, L. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.12.032 · Cited by 39 · see citing works
Zamarrón, E., Oriol, A. J., García‐Sánchez, A., Díaz-Cambriles, T., Alonso‐Fernández, A., Lores, V., Mediano, O., Rodríguez-Rodríguez, P., Cabello, S., Morales, E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85023-w · Cited by 38 · see citing works
Mandibular Advancement Devices for OSA: An Alternative to CPAP?
Francis, C. E., & Quinnell, T. (2021) · Pulmonary Therapy · doi:10.1007/s41030-020-00137-2 · Cited by 37 · see citing works
Tantrakul, V., Ingsathit, A., Liamsombut, S., Rattanasiri, S., Kittivoravitkul, P., Imsom-Somboon, N., Lertpongpiroon, S., Jantarasaengaram, S., Somchit, W., Suwansathit, W., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02445-y · Cited by 37 · see citing works
Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA
Schweitzer, P. K., Mayer, G., Rosenberg, R. P., Malhotra, A., Zammit, G. K., Gotfried, M. H., Chandler, P. A., Baladi, M. G., & Strohl, K. P. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.02.033 · Cited by 37 · see citing works
Management of obstructive sleep apnea in Europe – A 10-year follow-up
Fietze, I., Laharnar, N., Bargiotas, P., Başoğlu, Ö. K., Đogaš, Z., Drummond, M., Fanfulla, F., Gíslason, Þ., Gouveris, H. T., Grote, L., et al. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.06.001 · Cited by 37 · see citing works
The impact of obstructive sleep apnea on nonalcoholic fatty liver disease
Tang, H., Lv, F., Zhang, P., Liu, J., & Mao, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1254459 · Cited by 35 · see citing works
The Course of Obstructive Sleep Apnea Syndrome in Patients With Acromegaly During Treatment
Wolters, T. L. C., Roerink, S. H. P. P., Drenthen, L. C. A., van Haren-Willems, J., Wagenmakers, M. A. E. M., Smit, J. W. A., Hermus, A. R. M. M., & Netea-Maier, R. T. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz050 · Cited by 35 · see citing works
Telemedicine in Sleep-Disordered Breathing
Verbraecken, J. A. (2021) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2021.05.009 · Cited by 35 · see citing works
Hansen-Flaschen, J. H., & Ackrivo, J. (2023) · Respiratory Care · doi:10.4187/respcare.10349 · Cited by 34 · see citing works
Yang, R., Zhang, L., Guo, J., Wang, N., Zhang, Q., Qi, Z., Wu, L., Qin, L., & Liu, T. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06302-y · Cited by 34 · see citing works
Evaluation and Management of Sleep and Circadian Rhythm Disturbance in Cancer
Balachandran, D. D., Miller, M. A., Faiz, S. A., Yennurajalingam, S., & Innominato, P. F. (2021) · Current Treatment Options in Oncology · doi:10.1007/s11864-021-00872-x · Cited by 34 · see citing works
Potential Use of SGLT-2 Inhibitors in Obstructive Sleep Apnea: A new treatment on the horizon
Tanrıöver, C., Uçku, D., Akyol, M., Çevik, E., Kanbay, A., Sridhar, V. S., Cherney, D. Z. I., & Kanbay, M. (2022) · Sleep And Breathing · doi:10.1007/s11325-022-02606-1 · Cited by 33 · see citing works
Brazilian Thoracic Association Consensus on Sleep-disordered Breathing
Duarte, R., Togeiro, S. M., Palombini, L., Rizzatti, F. P. G., Fagondes, S. C., Magalhães-da-Silveira, F. J., Cabral, M. M., Genta, P. R., Lorenzi‐Filho, G., Clímaco, D. C. S., et al. (2022) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20220106 · Cited by 33 · see citing works
Cohen, O., Kundel, V., Barbé, F., Peker, Y., McEvoy, R. D., Sánchez‐de‐la‐Torre, M., Gottlieb, D. J., Bradley, T. D., Suárez‐Fariñas, M., Zinchuk, A. V., et al. (2024) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202409-981st · Cited by 33 · see citing works
Self-citationPartial failure of CPAP treatment for sleep apnoea: Analysis of the French national sleep database
Bailly, S., Daabek, N., Jullian‐Desayes, I., Joyeux‐Faure, M., Sapène, M., Grillet, Y., Borel, J., Tamisier, R., & Pépin, J. (2019) · Respirology · doi:10.1111/resp.13650 · Cited by 33 · see citing works
Telehealth, Telemedicine, and Obstructive Sleep Apnea
Schutte-Rodin, S. (2020) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2020.05.003 · Cited by 33 · see citing works
Ekström, M. P., Albrecht, D., Andersson, S., Grote, L., Rundström, B. K., Palm, A., Theorell‐Haglöw, J., Wahlberg, J., & Midgren, B. (2020) · ERJ Open Research · doi:10.1183/23120541.00340-2020 · Cited by 32 · see citing works
MicroRNAs to guide medical decision-making in obstructive sleep apnea: A review
Pinilla, L., Barbé, F., & de Gonzalo‐Calvo, D. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101458 · Cited by 32 · see citing works
Mattila, T., Hasala, H., Kreivi, H., Avellan-Hietanen, H., Bachour, A., Herse, F., Leskelä, R., Toppila-Salmi, S. K., Erhola, M., Haahtela, T., et al. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100338 · Cited by 32 · see citing works
Obstructive sleep apnoea-hypopnoea syndrome: state of the art
Tondo, P., Fanfulla, F., Sabato, R., Scioscia, G., Barbaro, M. P. F., & Lacedonia, D. (2022) · Minerva Medica · doi:10.23736/s0026-4806.22.08190-3 · Cited by 32 · see citing works
Lebret, M., Léotard, A., Pépin, J., Windisch, W., Ekkernkamp, E., Pallero, M., Sánchez-Quiroga, M.-Á., Hart, N., Kelly, J. L., Patout, M., et al. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-215613 · Cited by 31 · see citing works
Lurie, A., & Roche, N. (2021) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2021.1950663 · Cited by 31 · see citing works
Al-Halawani, M., Kyung, C., Liang, F., Kaplan, I., Moon, J., Clerger, G., Sabin, B., Barnes, A., & Al-Ajam, M. R. (2020) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.8176 · Cited by 30 · see citing works
Kreivi, H., Itäluoma, T., & Bachour, A. (2020) · ERJ Open Research · doi:10.1183/23120541.00101-2019 · Cited by 30 · see citing works
Baran, R., Grimm, D. G., Infanger, M., & Wehland, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052300 · Cited by 30 · see citing works
Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases
Tiotiu, A. I., Chong‐Neto, H. J., Bikov, A., Kowal, K., Steiropoulos, P., Labor, M., Chérrez-Ojeda, I., Badellino, H., Emelyanov, A. V., Garcia, R., et al. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1951707 · Cited by 30 · see citing works
Frange, C., Franco, A. M., Brasil, E. L., Hirata, R. P., Lino, J. A., Mortari, D. M., Ykeda, D. S., Leocádio-Miguel, M. A., D’Aurea, C. V. R., Silva, L. O. E., et al. (2022) · Sleep Science · doi:10.5935/1984-0063.20220083 · Cited by 30 · see citing works
Allen, A. M., Ceder, Y. K., Shochat, T., Fenig, E., Popovtzer, A., Bragilofsky, D., Alfassy, A., & Allon, H. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01505-7 · Cited by 29 · see citing works
Wang, D., Tang, Y., Chen, Y., Zhang, S., Ma, D., Luo, Y., Li, S., Su, X., Wang, X., Liu, C., et al. (2021) · SLEEP · doi:10.1093/sleep/zsab077 · Cited by 29 · see citing works
Sex-dependent effects of chronic intermittent hypoxia: implication for obstructive sleep apnea
Mabry, S., Bradshaw, J. L., Gardner, J. J., Wilson, E. N., & Cunningham, R. L. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00613-3 · Cited by 28 · see citing works
Donovan, L. M., Yu, L., Bertisch, S. M., Buysse, D. J., Rueschman, M., & Patel, S. R. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.11.011 · Cited by 28 · see citing works
Self-citationВладимировна, А. А., Анатольевна, С. О., Blinova, N. V., Danilov, N. M., Elfimova, E. M., Кislyak, O. A., Litvin, A. Y., Ощепкова, Е. В., Fomin, V. V., Михайловна, Ч. Н., et al. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.09.201007 · Cited by 28 · see citing works
Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update
Romigi, A., Feola, T., Cappellano, S., De Angelis, M., Pio, G., Caccamo, M., Testa, F., Vitrani, G., Centonze, D., Colonnese, C., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.817257 · Cited by 28 · see citing works
Chazova, I. E., Михайловна, Ч. Н., Blinova, N. V., Belaya, Z. E., Danilov, N. M., Elfimova, E. M., Litvin, A. Y., Rozhinskaya, L. Y., Sviridenko, N. Y., Швецов, М. Ю., et al. (2023) · Eurasian heart journal · doi:10.38109/2225-1685-2023-1-6-65 · Cited by 28 · see citing works
Jurado-García, A., Molina‐Recio, G., Collado, N. F., Palomares-Muriana, A., Gómez-González, A. M., Márquez-Pérez, F. L., & Gámez, B. J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176334 · Cited by 27 · see citing works
Role of precision medicine in obstructive sleep apnoea
Liu, Y., Ghafoor, A. A., Hajipour, M., & Ayas, N. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000218 · Cited by 27 · see citing works
Oxygen Therapy in Sleep-Disordered Breathing
Zeineddine, S., Rowley, J. A., & Chowdhuri, S. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.02.017 · Cited by 27 · see citing works
APAP, BPAP, CPAP, and New Modes of Positive Airway Pressure Therapy
Johnson, K. G. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-06413-5_18 · Cited by 26 · see citing works
Treatments for obstructive sleep apnea: CPAP and beyond
Aboussouan, L. S., Bhat, A., Coy, T., & Kominsky, A. H. (2023) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.90a.23032 · Cited by 26 · see citing works
Best practice guidelines in managing the craniofacial aspects of skeletal dysplasia
Savarirayan, R., Tunkel, D. E., Sterni, L. M., Bober, M. B., Cho, T., Goldberg, M. J., Hoover-Fong, J. E., Irving, M. D., Kamps, S. E., Mackenzie, W. G., et al. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01678-8 · Cited by 26 · see citing works
Wrzesień, A., Andrzejewski, K., Jampolska, M., & Kaczyńska, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042327 · Cited by 25 · see citing works
Gender medicine and sleep disorders: from basic science to clinical research
Perger, E., Silvestri, R., Bonanni, E., Perri, M. C. D., Fernandes, M., Provini, F., Zoccoli, G., & Lombardi, C. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1392489 · Cited by 25 · see citing works
Best Predictors of Continuous Positive Airway Pressure Adherence
Weaver, T. E. (2022) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2022.07.005 · Cited by 25 · see citing works
Lins-Filho, O., Germano-Soares, A. H., Aguiar, J. L. P., de Almedia, J. R. V., dos Santos, E. C. F., Lyra, M. J., Leite, D. B., Moura, M. A. S., Kline, C. E., & Pedrosa, R. P. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.11.008 · Cited by 25 · see citing works
Martin, J. L., Mysliwiec, V., Chowdhuri, S., & Ulmer, C. S. (2020) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.8486 · Cited by 25 · see citing works
Obstructive sleep apnea and risk of motor vehicle accident
Pocobelli, G. S., Akosile, M., Hansen, R. N., Eavey, J., Wellman, R., Johnson, R. L., Carls, G. S., Bron, M., & Dublin, S. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.07.019 · Cited by 24 · see citing works
Steier, J. S., Bogan, R., Pumarega, I. C., Fleetham, J. A., Insalaco, G., Lal, C., Pépin, J., Randerath, W. J., Redline, S. S., & Malhotra, A. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.10.001 · Cited by 24 · see citing works
- Authors
- Patil, S. P., Ayappa, I. A., Caples, S. M., Kimoff, R. J., Patel, S. R., & Harrod, C. G.
- Affiliations
- Johns Hopkins University (US)
- Icahn School of Medicine at Mount Sinai (US)
- Mayo Clinic (US)
- McGill University Health Centre (CA)
- University of Pittsburgh (US)
- American Academy of Sleep Medicine (US)
- Corresponding author
- Patil, Susheel P.
- Venue
- Journal of Clinical Sleep Medicine
- Published
- 2019-02-15
- Volume
- 15
- Issue
- 2
- Pages
- 335-343
- ISSN
- 1550-9389 (ISSN-L)
- 1550-9397
- PMC
- PMC6374094
- OpenAlex
- W2912654414
- Cited by
- 881
- References
- 18
- Citations by year
- 2026: 142 · 2025: 153 · 2024: 146 · 2023: 122 · 2022: 112 · 2021: 113 · 2020: 69 · 2019: 23
- FWCI
- 54.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Sleep Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Keywords
- obstructive sleep apnea, positive airway pressure, continuous positive airway pressure, paracetamol, medication adherence, excessive daytime sleepiness, sleep-related quality of life, hypertension, treatment follow-up, sleep apnea diagnosis, adults, clinical guidelines, sleep-disordered breathing, treatment response monitoring, patient values and preferences, resource utilization (health care), cost-effectiveness
- MeSH terms
- GRADE Approach, Adult, Humans, Positive-Pressure Respiration, United States, Treatment Outcome, Sleep Apnea, Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
